Carmot Therapeutics
ID: 5291619A biotechnology company developing drugs for the treatment of metabolic diseases, cancer and inflammation
4
Funding Rounds
$223.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| St** K. Ha**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Carmot Therapeutics has raised a total of $208.55m in funding over 4 rounds.
Key Insights:
- Carmot Therapeutics Inc. Funding Round, August 2022: $160m
- Carmot Therapeutics Series C round, September 2020: $47m
- Carmot Therapeutics funding round, April 2010: $1.55m
- Carmot Therapeutics Inc funding round, January 2018: $15m
Industries
Carmot Therapeutics is active in the following industries: